Switch theme
Sign up to access all valuation multiples
Asker Healthcare Group AB is a provider of medical products and solutions that drive progress in the European healthcare sector. The company is engaged in building and acquiring companies to support the healthcare system to improve patient outcomes, reduce the total cost of care, and ensure a fair and sustainable value chain. The company also offers a range of value-added solutions to support its suppliers and customers in, for example, market access, efficiency, and sustainability.
2006
4.0K+
LTM Revenue $1.6B
LTM EBITDA $183M
$4.5B
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
Asker Healthcare Group has a last 12-month revenue (LTM) of $1.6B and a last 12-month EBITDA of $183M.
In the most recent fiscal year, Asker Healthcare Group achieved revenue of $1.5B and an EBITDA of $152M.
Asker Healthcare Group expects next 12-month revenue of XXX and NTM EBITDA of XXX
See Asker Healthcare Group valuation multiples based on analyst estimates| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue | $1.6B | XXX | $1.5B | XXX | XXX | XXX |
| Gross Profit | $374M | XXX | $606M | XXX | XXX | XXX |
| Gross Margin | 23% | XXX | 39% | XXX | XXX | XXX |
| EBITDA | $183M | XXX | $152M | XXX | XXX | XXX |
| EBITDA Margin | 11% | XXX | 10% | XXX | XXX | XXX |
| EBIT | $126M | XXX | $100M | XXX | XXX | XXX |
| EBIT Margin | 8% | XXX | 6% | XXX | XXX | XXX |
| Net Profit | $57.3M | XXX | $37.1M | XXX | XXX | XXX |
| Net Margin | 4% | XXX | 2% | XXX | XXX | XXX |
| Net Debt | XXX | XXX | $465M | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of May 30, 2025, Asker Healthcare Group's stock price is SEK 100 (or $10).
Asker Healthcare Group has current market cap of SEK 40.2B (or $4.1B), and EV of SEK 43.7B (or $4.5B).
See Asker Healthcare Group trading valuation data| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $4.5B | $4.1B | XXX | XXX | XXX | XXX | $0.23 |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Start Free TrialAs of May 30, 2025, Asker Healthcare Group has market cap of $4.1B and EV of $4.5B.
Asker Healthcare Group's trades at 2.9x EV/Revenue multiple, and 29.8x EV/EBITDA.
Equity research analysts estimate Asker Healthcare Group's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Asker Healthcare Group has a P/E ratio of 72.3x.
See valuation multiples for Asker Healthcare Group and 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $4.1B | XXX | $4.1B | XXX | XXX | XXX |
| EV (current) | $4.5B | XXX | $4.5B | XXX | XXX | XXX |
| EV/Revenue | 2.8x | XXX | 2.9x | XXX | XXX | XXX |
| EV/EBITDA | 24.7x | XXX | 29.8x | XXX | XXX | XXX |
| EV/EBIT | 35.7x | XXX | 45.0x | XXX | XXX | XXX |
| EV/Gross Profit | 12.1x | XXX | n/a | XXX | XXX | XXX |
| P/E | 72.3x | XXX | 111.7x | XXX | XXX | XXX |
| EV/FCF | 79.6x | XXX | 49.7x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Start Free TrialAsker Healthcare Group's last 12 month revenue growth is 11%
Asker Healthcare Group's revenue per employee in the last FY averaged $0.4M, while opex per employee averaged $0.1M for the same period.
Asker Healthcare Group's rule of 40 is 19% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Asker Healthcare Group's rule of X is 39% (created by Bessemer, rule of X is another metric relevant for SaaS companies only, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
See operational valuation multiples for Asker Healthcare Group and other 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue Growth | 11% | XXX | 11% | XXX | XXX | XXX |
| EBITDA Margin | 11% | XXX | 10% | XXX | XXX | XXX |
| EBITDA Growth | 16% | XXX | 32% | XXX | XXX | XXX |
| Rule of 40 | 19% | XXX | 21% | XXX | XXX | XXX |
| Bessemer Rule of X | XXX | XXX | 39% | XXX | XXX | XXX |
| Revenue per Employee | XXX | XXX | $0.4M | XXX | XXX | XXX |
| Opex per Employee | XXX | XXX | $0.1M | XXX | XXX | XXX |
| S&M Expenses to Revenue | XXX | XXX | 23% | XXX | XXX | XXX |
| G&A Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| R&D Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| Opex to Revenue | XXX | XXX | 33% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| 2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
| Burjeel Holdings | XXX | XXX | XXX | XXX | XXX | XXX |
| PureHealth | XXX | XXX | XXX | XXX | XXX | XXX |
| Integral Diagnostics | XXX | XXX | XXX | XXX | XXX | XXX |
| Ramsay Health | XXX | XXX | XXX | XXX | XXX | XXX |
| Athens Medical Centre | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Asker Healthcare Group acquired XXX companies to date.
Last acquisition by Asker Healthcare Group was XXXXXXXX, XXXXX XXXXX XXXXXX . Asker Healthcare Group acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiples| Acquired Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Start Free Trial| When was Asker Healthcare Group founded? | Asker Healthcare Group was founded in 2006. |
| Where is Asker Healthcare Group headquartered? | Asker Healthcare Group is headquartered in Sweden. |
| How many employees does Asker Healthcare Group have? | As of today, Asker Healthcare Group has 4.0K+ employees. |
| Is Asker Healthcare Group publicy listed? | Yes, Asker Healthcare Group is a public company listed on STO. |
| What is the stock symbol of Asker Healthcare Group? | Asker Healthcare Group trades under ASKER ticker. |
| When did Asker Healthcare Group go public? | Asker Healthcare Group went public in 2025. |
| Who are competitors of Asker Healthcare Group? | Similar companies to Asker Healthcare Group include e.g. Burjeel Holdings, PureHealth, Integral Diagnostics, Ramsay Health. |
| What is the current market cap of Asker Healthcare Group? | Asker Healthcare Group's current market cap is $4.1B |
| What is the current revenue of Asker Healthcare Group? | Asker Healthcare Group's last 12 months revenue is $1.6B. |
| What is the current revenue growth of Asker Healthcare Group? | Asker Healthcare Group revenue growth (NTM/LTM) is 11%. |
| What is the current EV/Revenue multiple of Asker Healthcare Group? | Current revenue multiple of Asker Healthcare Group is 2.8x. |
| Is Asker Healthcare Group profitable? | Yes, Asker Healthcare Group is EBITDA-positive (as of the last 12 months). |
| What is the current EBITDA of Asker Healthcare Group? | Asker Healthcare Group's last 12 months EBITDA is $183M. |
| What is Asker Healthcare Group's EBITDA margin? | Asker Healthcare Group's last 12 months EBITDA margin is 11%. |
| What is the current EV/EBITDA multiple of Asker Healthcare Group? | Current EBITDA multiple of Asker Healthcare Group is 24.7x. |
| What is the current FCF of Asker Healthcare Group? | Asker Healthcare Group's last 12 months FCF is $56.7M. |
| What is Asker Healthcare Group's FCF margin? | Asker Healthcare Group's last 12 months FCF margin is 3%. |
| What is the current EV/FCF multiple of Asker Healthcare Group? | Current FCF multiple of Asker Healthcare Group is 79.6x. |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.
